Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.45 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 6/20 | 0.43 |
| ▸ | CTSD | P07339 | 2/20 | 0.43 |
| ▸ | ECE1 | P42892 | 2/20 | 0.41 |
| ▸ | CTSC | P53634 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590576 | 0.96 | PDCD1LG2 (0.44) | PDCD1LG2CD274BACE1CTSDECE1 | |
| SCHEMBL30903445 | 0.91 | CD274 (0.51) | PDCD1LG2CD274BACE1CTSDECE1 | |
| SCHEMBL30122998 | 0.89 | BACE1 (0.47) | BACE1CTSDENPEP | |
| SCHEMBL29630814 | 0.88 | ECE1 (0.51) | PDCD1LG2CD274BACE1CTSDECE1 | |
| SCHEMBL29498236 | 0.87 | BACE1 (0.41) | BACE1CTSDECE1CTSCENPEP | |
| SCHEMBL30973959 | 0.87 | FOLH1 (0.43) | PDCD1LG2CD274BACE1CTSDECE1 | |
| SCHEMBL2492391 | 0.87 | CTSC (0.47) | ECE1CTSC | |
| SCHEMBL8427081 | 0.87 | CTSC (0.47) | ECE1CTSC | |
| SCHEMBL2492394 | 0.87 | CTSC (0.47) | ECE1CTSC | |
| SCHEMBL8427089 | 0.87 | CTSC (0.47) | ECE1CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |